Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbing Zhang

Showing results (191-200 of 269) with videos related to

Pageof 27
Sort By:
Oncotarget|April 15, 2016
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiencyHongwu Li, Fuquan Jin, Keguo Jiang, et al.
Frontiers in Immunology|September 13, 2021
<i>ARID1A, ARID1B</i>, and <i>ARID2</i> Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung CancerGuangsheng Zhu, Ruifeng Shi, Yongwen Li, et al.
BMC Geriatrics|August 12, 2022
Level-specific associations of urinary antimony with cognitive function in US older adults from the National Health and Nutrition Examination Survey 2011-2014Xiangdong Wang, Rui Wang, Zeyao Zhang, et al.
Frontiers in Immunology|May 9, 2022
Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature ModelLei Wang, Hongbing Zhang, Chaohu Pan, et al.
Journal of Cancer|August 5, 2017
MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancerYongwen Li, Hongbing Zhang, Yunlong Dong, et al.
Journal of Gastroenterology and Hepatology|March 30, 2011
Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survivalYongliang Sun, Huayu Yang, Yilei Mao, et al.
Stem Cells and Development|April 5, 2012
An elaborate regulation of Mammalian target of rapamycin activity is required for somatic cell reprogramming induced by defined transcription factorsJing He, Lan Kang, Tong Wu, et al.
Cancer Letters|January 13, 2015
NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growthXiaojun Zha, Zhongdong Hu, Shuang Ji, et al.
Thoracic Cancer|May 21, 2025
Anlotinib Plus Osimertinib in Osimertinib-Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective StudyYu Hua, Minghui Liu, Boshi Li, et al.
Expert Review of Respiratory Medicine|September 11, 2024
Omics research in lymphangioleiomyomatosis: status and challengesXinhe Zhang, Song Liu, Luning Yang, et al.
Pageof 27

Showing results (191-200 of 269) with videos related to

Sort By:
Pageof 27
Oncotarget|April 15, 2016
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiencyHongwu Li, Fuquan Jin, Keguo Jiang, et al.
Frontiers in Immunology|September 13, 2021
<i>ARID1A, ARID1B</i>, and <i>ARID2</i> Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung CancerGuangsheng Zhu, Ruifeng Shi, Yongwen Li, et al.
BMC Geriatrics|August 12, 2022
Level-specific associations of urinary antimony with cognitive function in US older adults from the National Health and Nutrition Examination Survey 2011-2014Xiangdong Wang, Rui Wang, Zeyao Zhang, et al.
Frontiers in Immunology|May 9, 2022
Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature ModelLei Wang, Hongbing Zhang, Chaohu Pan, et al.
Journal of Cancer|August 5, 2017
MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancerYongwen Li, Hongbing Zhang, Yunlong Dong, et al.
Journal of Gastroenterology and Hepatology|March 30, 2011
Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survivalYongliang Sun, Huayu Yang, Yilei Mao, et al.
Stem Cells and Development|April 5, 2012
An elaborate regulation of Mammalian target of rapamycin activity is required for somatic cell reprogramming induced by defined transcription factorsJing He, Lan Kang, Tong Wu, et al.
Cancer Letters|January 13, 2015
NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growthXiaojun Zha, Zhongdong Hu, Shuang Ji, et al.
Thoracic Cancer|May 21, 2025
Anlotinib Plus Osimertinib in Osimertinib-Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective StudyYu Hua, Minghui Liu, Boshi Li, et al.
Expert Review of Respiratory Medicine|September 11, 2024
Omics research in lymphangioleiomyomatosis: status and challengesXinhe Zhang, Song Liu, Luning Yang, et al.
Pageof 27